For this purpose, in this work we performed a genetic screening for germline BRCA1 and BRCA2 PVs in Sicilian breast and/or ovarian cancer patients and their relatives, in order to assess the prevalence and typology of these high-risk susceptibility variants in individuals belonging to this specific geographical area of Southern Italy. This evidence concerns the gene BRCA1 and ovarian carcinoma.